BNP Paribas Financial Markets’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $61.8K | Sell |
2,230
-1,548
| -41% | -$36.5K | ﹤0.01% | 4785 |
|
|
2026
Q1 | $81.6K | Sell |
3,778
-31
| -0.8% | -$572 | ﹤0.01% | 4471 |
|
|
2025
Q4 | $52.3K | Buy |
3,809
+329
| +9% | +$5.13K | ﹤0.01% | 4668 |
|
|
2025
Q3 | $61.6K | Buy |
3,480
+1,731
| +99% | +$27.4K | ﹤0.01% | 4509 |
|
|
2025
Q2 | $26.4K | Buy |
1,749
+680
| +64% | +$11.3K | ﹤0.01% | 4489 |
|
|
2025
Q1 | $17.2K | Sell |
1,069
-918
| -46% | -$17.1K | ﹤0.01% | 4576 |
|
|
2024
Q4 | $34.6K | Sell |
1,987
-1,663
| -46% | -$29.3K | ﹤0.01% | 4564 |
|
|
2024
Q3 | $64K | Sell |
3,650
-84
| -2% | -$1.43K | ﹤0.01% | 3566 |
|
|
2024
Q2 | $41.8K | Sell |
3,734
-3,863
| -51% | -$36.4K | ﹤0.01% | 3495 |
|
|
2024
Q1 | $66.2K | Buy |
7,597
+2,952
| +64% | +$27.1K | ﹤0.01% | 3533 |
|
|
2023
Q4 | $56.9K | Sell |
4,645
-361
| -7% | -$2.5K | ﹤0.01% | 3537 |
|
|
2023
Q3 | $20.2K | Buy |
5,006
+807
| +19% | +$5.01K | ﹤0.01% | 3563 |
|
|
2023
Q2 | $30.2K | Buy |
4,199
+3,683
| +714% | +$23.5K | ﹤0.01% | 3555 |
|
|
2023
Q1 | $1.73K | Sell |
516
-241
| -32% | -$727 | ﹤0.01% | 3644 |
|
|
2022
Q4 | $2.1K | Hold |
757
| – | – | ﹤0.01% | 3735 |
|
|
2022
Q3 | $1.74K | Sell |
757
-1,445
| -66% | -$2.35K | ﹤0.01% | 4361 |
|
|
2022
Q2 | $3.37K | Buy |
2,202
+961
| +77% | +$2.42K | ﹤0.01% | 3848 |
|
|
2022
Q1 | $6.03K | Sell |
1,241
-1,757
| -59% | -$14.4K | ﹤0.01% | 3844 |
|
|
2021
Q4 | $44.4K | Sell |
2,998
-103
| -3% | -$2.05K | ﹤0.01% | 3761 |
|
|
2021
Q3 | $67K | Buy |
3,101
+2,047
| +194% | +$44K | ﹤0.01% | 3432 |
|
|
2021
Q2 | $17.3K | Sell |
1,054
-942
| -47% | -$17.9K | ﹤0.01% | 3566 |
|
|
2021
Q1 | $47.3K | Sell |
1,996
-704
| -26% | -$21K | ﹤0.01% | 3624 |
|
|
2020
Q4 | $64.4K | Sell |
2,700
-1,623
| -38% | -$25.8K | ﹤0.01% | 3436 |
|
|
2020
Q3 | $51K | Buy |
4,323
+3,073
| +246% | +$33.1K | ﹤0.01% | 3458 |
|
|
2020
Q2 | $13.1K | Sell |
1,250
-2,250
| -64% | -$20.3K | ﹤0.01% | 3594 |
|
|
2020
Q1 | $25.1K | Buy |
3,500
+1,906
| +120% | +$19.8K | ﹤0.01% | 3845 |
|
|
2019
Q4 | $21.4K | Sell |
1,594
-196
| -11% | -$2.79K | ﹤0.01% | 3984 |
|
|
2019
Q3 | $27.6K | Buy |
1,790
+544
| +44% | +$7.07K | ﹤0.01% | 3803 |
|
|
2019
Q2 | $16.4K | Sell |
1,246
-1,013
| -45% | -$13.8K | ﹤0.01% | 3967 |
|
|
2019
Q1 | $39.7K | Buy |
2,259
+2,068
| +1,083% | +$32.4K | ﹤0.01% | 3629 |
|
|
2018
Q4 | $2.19K | Sell |
191
-160
| -46% | -$1.94K | ﹤0.01% | 3786 |
|
|
2018
Q3 | $4.98K | Sell |
351
-24
| -6% | -$341 | ﹤0.01% | 4065 |
|
|
2018
Q2 | $5.68K | Sell |
375
-1,766
| -82% | -$29.9K | ﹤0.01% | 4044 |
|
|
2018
Q1 | $29K | Buy |
2,141
+120
| +6% | +$2.28K | ﹤0.01% | 3808 |
|
|
2017
Q4 | $47.7K | Buy |
2,021
+714
| +55% | +$16.9K | ﹤0.01% | 3687 |
|
|
2017
Q3 | $24.3K | Buy |
1,307
+352
| +37% | +$8K | ﹤0.01% | 3497 |
|
|
2017
Q2 | $33K | Buy |
+955
| New | +$26.3K | ﹤0.01% | 3398 |
|
Other funds holding PLSE
PCM
BNP Paribas Financial Markets's PLSE Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its Pulse Biosciences (PLSE) stake by 41% in Q2 2026, selling an estimated $36.5K and leaving 2,230 shares worth $61.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4785.
BNP Paribas Financial Markets first reported a position in PLSE in Q2 2017 and has held it in 37 quarters since. The position peaked at $81.6K in Q1 2026. 99 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.
- BNP Paribas Financial Markets held 2,230 shares of Pulse Biosciences worth $61.8K as of Q2 2026.
- BNP Paribas Financial Markets sold 1,548 Pulse Biosciences shares in Q2 2026, an estimated $36.5K.
- Pulse Biosciences made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4785 holding.
- BNP Paribas Financial Markets first reported a position in Pulse Biosciences in Q2 2017 and has held it in 37 quarters since.
- BNP Paribas Financial Markets's Pulse Biosciences position peaked at $81.6K in Q1 2026.
- 99 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.